These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Insulin resistance caused by an increase in proteolytic enzyme activity at the site of insulin injection. Study in insulin-dependent diabetic subjects]. Calle Pascual AL; Marañes Pallardó JP; Charro Salgado AL Med Clin (Barc); 1983 Apr; 80(12):524-6. PubMed ID: 6191160 [No Abstract] [Full Text] [Related]
24. [Non-specific cellular and humoral immunity in diabetic patients]. Durić D; Protić-Hlusica D; Ljaljević J; Vulević I; Nesović M Srp Arh Celok Lek; 1976; 104(3-4):209-18. PubMed ID: 1019731 [No Abstract] [Full Text] [Related]
25. Receptor-mediated endocytosis of insulin: inhibition of [125I]iodoinsulin internalization in insulin resistant diabetic states of man. Grunberger G; Geiger D; Carpentier JL; Robert A; Gorden P Acta Endocrinol (Copenh); 1989 Oct; 121(4):581-6. PubMed ID: 2678873 [TBL] [Abstract][Full Text] [Related]
26. [Cellular immunity in diabetes mellitus. The role of insulin deficiency]. Corral Corral C Rev Clin Esp; 1982 Apr; 165(1):1-4. PubMed ID: 6750705 [No Abstract] [Full Text] [Related]
27. [Cellular immunological reactions to insulin and pancreatic tissue in diabetes mellitus patients not treated with insulin]. Vel'bri SK Probl Endokrinol (Mosk); 1977; 23(2):15-20. PubMed ID: 905242 [TBL] [Abstract][Full Text] [Related]
28. Treatment of resistant diabetes mellitus. Field JB Mod Treat; 1967 Jan; 4(1):16-30. PubMed ID: 6018264 [No Abstract] [Full Text] [Related]
29. [Saluretic therapy and insulin resistance in diabetes mellitus]. Schwarzbach W; Haas W Med Klin; 1966 Dec; 61(51):2032-5. PubMed ID: 5996571 [No Abstract] [Full Text] [Related]
30. Depression of cell-mediated immunity in diabetes. Eliashiv A; Olumide F; Norton L; Eiseman B Arch Surg; 1978 Oct; 113(10):1180-3. PubMed ID: 309322 [TBL] [Abstract][Full Text] [Related]
31. [Alterations in natural immunity and risk of infection in patients with diabetes mellitus]. Moutschen M Rev Med Liege; 2005; 60(5-6):541-4. PubMed ID: 16035324 [TBL] [Abstract][Full Text] [Related]
32. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Bagdade JD; Stewart M; Walters E Diabetes; 1978 Jun; 27(6):677-81. PubMed ID: 658613 [TBL] [Abstract][Full Text] [Related]
34. Immune dysfunction in patients with diabetes mellitus (DM). Geerlings SE; Hoepelman AI FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):259-65. PubMed ID: 10575137 [TBL] [Abstract][Full Text] [Related]
35. Hyperglycaemia and ketosis in a non-diabetic patient--an unusual cause of delayed recovery. Pawar ST; Nath SS; Ansari F Anaesthesiol Intensive Ther; 2014; 46(3):171-4. PubMed ID: 25078770 [TBL] [Abstract][Full Text] [Related]
36. Immune and inflammatory processes in obesity, insulin resistance, diabetes, and related cardiometabolic complications. Ndisang JF; Rastogi S; Vannacci A J Immunol Res; 2014; 2014():579560. PubMed ID: 25328894 [No Abstract] [Full Text] [Related]
37. [Serum immunoglobulins of the main classes in diabetic patients]. Hrncír Z; Tichý M; Fixa B Cas Lek Cesk; 1974 Feb; 113(5):137-40. PubMed ID: 4434426 [No Abstract] [Full Text] [Related]
38. [Apropos of the association of obstructive jaundice and insulin-resistant diabetes]. Remignon M; Anglade JP; Febvey M; Robichon Bull Mens Soc Med Mil Fr; 1965 Nov; 59(9):497-9. PubMed ID: 5898139 [No Abstract] [Full Text] [Related]